News


( Last Updated : March 7, 2015)

November 25, 2021
The CADTH Therapeutic Review of treatments for transplant-ineligible multiple myeloma patients represents several firsts for the organization. It is CADTH’s first therapeutic review in oncology, and its first involving international collaboration. It also showcases many of the progressive aspects…
November 4, 2021
Today CADTH published new recommendations that offer advice to pan-Canadian health systems on how to implement remote monitoring programs for patients with chronic cardiac conditions. These recommendations emphasize patient, caregiver, and provider considerations, data and privacy, digital equity,…
October 8, 2021
Suzanne McGurn, President and CEO of CADTH, is pleased to announce the appointment of new members of the CADTH Canadian Drug Expert Committee (CDEC) and the CADTH pan-Canadian Oncology Drug Review (pCODR) Expert Review Committee (pERC), as well as a new chair and new members of the Health…
October 8, 2021
CADTH is pleased to announce the appointment of 5 new members to the CADTH Board of Directors. “I am pleased to welcome Hamida Bhimani, Avram Denburg, Chad Mitchell, Mark Wies, and Eric Bélair to the Board of Directors and look forward to the insight and leadership they will bring to CADTH,” said…
October 4, 2021
A statement from Suzanne McGurn, President and CEO, CADTH On behalf of CADTH and our Board of Directors, I’m pleased to share CADTH’s Annual Report for 2020–2021, my first as President and CEO. Read the Report The theme of this year’s report — “unprecedented,” — is in recognition of a year like…